Glucose-dependent granule docking limits insulin secretion and is decreased in human type 2 diabetes
Be aware that only Wegovy and Zepbound are FDA-approved for weight management
The anti-aging effects of Sermorelin are mainly provided by its capacity to increase the generation of GH
[6] [7] For weight management, NICE technology appraisals (TA875 for Wegovy, TA664 for Saxenda) specify use within specialist weight management services for people with a BMI of at least 35 kg/m (or 30 kg/m with weight-related comorbidities) and following unsuccessful lifestyle interventions
It is not a weight-loss drug
Pharmacokinetic comparisons between diabetic individuals and healthy individuals have shown that tirzepatide delays gastric emptying, particularly after a single dose, and demonstrates a decrease in effectiveness or responsiveness with repeated once-weekly dosing, referred to as tachyphylaxis [44, 72]